Antineoplastic and immunomodulating agents

Summary

The tender concerns a framework agreement for oncological medicines, divided into 12 lots. The contract is expected to start on 18 October 2026, or earlier if the framework quantity is exhausted; for lot 5 (cemiplimab), the framework agreement starts on the date of award. Clarification requests must be submitted in SEAP, and the contracting authority answers them 11 days before the deadline for tenders. The machine-readable notice did not include precise qualification or exclusion requirements; these must be checked in the official tender documents.